0,848  0,003  Caspase 3 stimulant
0,839  0,012  Apoptosis agonist
0,826  0,008  Caspase 9 stimulant
0,814  0,007  Antineoplastic (lung cancer)
0,770  0,005  Antineoplastic (non-small cell lung cancer)
0,708  0,006  Antineoplastic (melanoma)
0,719  0,018  Antineoplastic (breast cancer)
0,697  0,004  Cardiodepressant
0,691  0,005  CYP2C19 inhibitor
0,676  0,005  Antineoplastic (brain cancer)
0,673  0,012  Prostate cancer treatment
0,654  0,010  5 Hydroxytryptamine release stimulant
0,642  0,005  Antineoplastic (carcinoma)
0,653  0,018  Antileukemic
0,621  0,007  Antineoplastic (glioma)
0,615  0,005  Antineoplastic (glioblastoma multiforme)
0,614  0,005  Tubulin antagonist
0,611  0,005  Antineoplastic (lymphoma)
0,615  0,012  12-Lipoxygenase inhibitor
0,606  0,004  Anesthetic general
0,621  0,021  Antineoplastic (colorectal cancer)
0,620  0,020  Antineoplastic (colon cancer)
0,603  0,013  CYP2D6 substrate
0,597  0,008  Antineoplastic (multiple myeloma)
0,571  0,017  Sensitization
0,558  0,005  Antineoplastic (squamous cell carcinoma)
0,557  0,006  Antineoplastic (renal cancer)
0,561  0,013  NOS2 expression inhibitor
0,553  0,020  Antineoplastic (ovarian cancer)
0,561  0,036  Transcription factor NF kappa B inhibitor
0,539  0,014  Lipoxygenase inhibitor
0,530  0,012  CYP1A2 inhibitor
0,526  0,010  CYP3A4 inhibitor
0,546  0,032  15-Lipoxygenase inhibitor
0,523  0,020  Antineoplastic (cervical cancer)
0,523  0,021  CYP1A2 substrate
0,505  0,007  Hepatoprotectant
0,511  0,018  Chemopreventive
0,503  0,015  Antipyretic
0,507  0,019  Antioxidant
0,502  0,016  Free radical scavenger
0,502  0,022  Hepatic disorders treatment
0,488  0,008  Muscle relaxant
0,487  0,013  Antimitotic
0,466  0,010  P-glycoprotein inhibitor
0,481  0,026  Spasmolytic
0,458  0,008  Genotoxic
0,449  0,004  Alpha tubulin antagonist
0,517  0,076  Alpha-glucosidase inhibitor
0,467  0,027  Radioprotector
0,463  0,026  Antineoplastic (pancreatic cancer)
0,513  0,082  Antiinflammatory
0,451  0,023  Vasodilator, coronary
0,440  0,017  Psychostimulant
0,465  0,044  CYP2C9 substrate
0,427  0,008  Skeletal muscle relaxant
0,434  0,022  Nitric oxide antagonist
0,433  0,027  CYP2D6 inhibitor
0,438  0,038  Respiratory analeptic
0,417  0,020  Antineoplastic (liver cancer)
0,416  0,020  Vasodilator
0,406  0,021  Antihypertriglyceridemic
0,419  0,035  AR expression inhibitor
0,392  0,008  Liver fibrosis treatment
0,395  0,013  Antiseptic
0,408  0,028  Antiprotozoal (Leishmania)
0,408  0,029  UGT2B4 substrate
0,388  0,021  Antineoplastic (lymphocytic leukemia)
0,372  0,005  Breast cancer-resistant protein inhibitor
0,377  0,014  Melanin inhibitor
0,414  0,051  CYP2C9 inhibitor
0,410  0,060  CYP3A4 substrate
0,360  0,015  Male reproductive disfunction treatment
0,368  0,033  Antihypoxic
0,336  0,008  Carcinogenic, group 2B
0,357  0,037  Carcinogenic
0,393  0,079  Histamine release inhibitor
0,354  0,041  Cytostatic
0,384  0,072  Prostaglandin dehydrogenase inhibitor
0,319  0,009  Carcinogenic, group 1
0,335  0,033  Sigma receptor agonist
0,329  0,029  Abortion inducer
0,319  0,021  VCAM1 expression inhibitor
0,363  0,066  Angiogenesis inhibitor
0,352  0,055  Apoptosis antagonist
0,354  0,060  ICAM1 expression inhibitor
0,312  0,019  Skin whitener
0,317  0,024  Antimutagenic
0,292  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,330  0,047  DNA damaging
0,285  0,004  CDC-like kinase 3 inhibitor
0,299  0,018  Neurotrophic factor enhancer
0,393  0,112  Transcription factor inhibitor
0,333  0,055  Antihypercholesterolemic
0,358  0,083  Immunosuppressant
0,366  0,092  TNF expression inhibitor
0,277  0,004  Inducible nitric-oxide synthase inhibitor
0,277  0,005  Beta tubulin antagonist
0,322  0,054  Antineoplastic (small cell lung cancer)
0,273  0,008  UGT2B10 substrate
0,282  0,018  Erectile dysfunction treatment
0,295  0,034  Sedative
0,270  0,014  CDC-like kinase 1 inhibitor
0,266  0,012  Alpha 2b adrenoreceptor antagonist
0,317  0,065  Analeptic
0,344  0,095  Antiprotozoal
0,292  0,046  Antiulcerative
0,298  0,053  Proliferative diseases treatment
0,247  0,005  Phosphodiesterase V inhibitor
0,256  0,016  Topoisomerase I inhibitor
0,242  0,005  Carcinogenic, group 2A
0,231  0,004  Endothelin receptor antagonist
0,231  0,005  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,230  0,005  Phosphodiesterase 5A inhibitor
0,249  0,025  Topoisomerase II inhibitor
0,236  0,012  Microtubule formation inhibitor
0,291  0,070  Hypoxia-inducible factor 1 alpha inhibitor
0,230  0,011  Cyclooxygenase 3 inhibitor
0,224  0,014  Alpha 2c adrenoreceptor antagonist
0,238  0,029  Skin irritative effect
0,222  0,014  Alpha 2 adrenoreceptor antagonist
0,265  0,058  5 Hydroxytryptamine 1E antagonist
0,296  0,091  Antithrombotic
0,229  0,027  Heat shock protein 90 antagonist
0,253  0,053  Mutagenic
0,230  0,031  Lipid peroxidase inhibitor
0,270  0,074  GST M1-1 substrate
0,221  0,025  MAO A inhibitor
0,286  0,097  FMO1 substrate
0,299  0,111  GST A substrate
0,198  0,009  Nitric-oxide synthase inhibitor
0,223  0,035  MAO inhibitor
0,258  0,071  Tumour necrosis factor alpha release inhibitor
0,191  0,005  Phosphodiesterase 11A inhibitor
0,191  0,005  Phosphodiesterase XI inhibitor
0,335  0,152  Antineoplastic (solid tumors)
0,257  0,076  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,278  0,098  Bone diseases treatment
0,203  0,024  5-Lipoxygenase inhibitor
0,284  0,110  Antiprotozoal (Plasmodium)
0,249  0,077  Hypoglycemic
0,204  0,033  Cyclooxygenase 1 inhibitor
0,211  0,040  Amylase inhibitor
0,227  0,058  Platelet adhesion inhibitor
0,172  0,004  Potassium channel Kv1.3 blocker
0,321  0,154  DNA polymerase beta inhibitor
0,182  0,019  Antineoplastic alkaloid
0,202  0,039  Anesthetic
0,174  0,012  Transcription factor NF kappa B stimulant
0,165  0,003  Endothelin B receptor antagonist
0,259  0,098  Antiischemic
0,163  0,004  Endothelin A receptor antagonist
0,197  0,039  Phobic disorders treatment
0,200  0,042  UGT2B15 substrate
0,208  0,050  5 Hydroxytryptamine 3E antagonist
0,217  0,061  UGT1A1 substrate
0,295  0,139  Antibacterial
0,194  0,039  Carcinogenic, group 3
0,222  0,071  Pyruvate kinase inhibitor
0,203  0,052  LDLR expression enhancer
0,248  0,098  Cardioprotectant
0,177  0,028  Adenylate cyclase stimulant
0,168  0,020  Topoisomerase II alpha inhibitor
0,184  0,037  Anesthetic local
0,162  0,016  DOPA decarboxylase inhibitor
0,170  0,023  Vanilloid 1 agonist
0,204  0,065  CYP2B6 inhibitor
0,215  0,077  Antiparasitic
0,178  0,041  NADPH oxidase inhibitor
0,178  0,041  Antifungal enhancer
0,150  0,015  UGT2B11 substrate
0,161  0,027  Alcohol dehydrogenase substrate
0,208  0,075  Cytotoxic
0,234  0,103  CYP2C19 substrate
0,160  0,030  Butyrylcholinesterase inhibitor
0,243  0,114  Antifungal
0,293  0,165  DNA directed DNA polymerase inhibitor
0,167  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,182  0,055  Protein-tyrosine phosphatase inhibitor
0,170  0,044  Acetylcholinesterase inhibitor
0,302  0,177  MAP kinase 1 inhibitor
0,143  0,019  Antiviral (Coronavirus)
0,143  0,019  Antiviral (SARS coronavirus)
0,180  0,057  Antiviral (Herpes)
0,145  0,024  Calcium antagonist
0,219  0,099  Antineoplastic (sarcoma)
0,167  0,048  Bone formation stimulant
0,155  0,037  Interleukin 1b antagonist
0,127  0,013  Prostaglandin EP2 antagonist
0,115  0,005  Exportin-1 inhibitor
0,257  0,148  GABA C receptor rho-3 antagonist
0,191  0,083  Pneumotoxic
0,150  0,046  Heat shock protein 70 antagonist
0,112  0,010  Endocannabinoid uptake inhibitor
0,109  0,010  Antitreponemal
0,165  0,067  Uterine stimulant
0,213  0,116  Antiosteoporotic
0,144  0,049  Monophenol monooxygenase inhibitor
0,115  0,020  Lipase inhibitor
0,232  0,138  Antineoplastic (osteosarcoma)
0,165  0,072  UGT1A3 substrate
0,189  0,096  Antiparkinsonian, rigidity relieving
0,213  0,120  Chemoprotective
0,194  0,102  Dyrk kinase inhibitor
0,134  0,042  Choleretic
0,119  0,027  CYP2A6 inhibitor
0,113  0,022  Vanilloid agonist
0,205  0,115  DNA synthesis inhibitor
0,170  0,081  Myocardial ischemia treatment
0,110  0,021  GABA aminotransferase inhibitor
0,102  0,014  Alpha 2 adrenoreceptor agonist
0,156  0,069  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,092  0,005  Ryanodine receptor antagonist
0,154  0,069  Antiischemic, cerebral
0,185  0,102  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,225  0,144  Cholesterol antagonist
0,152  0,071  Acaricide
0,084  0,006  Factor III inhibitor
0,126  0,049  Mucolytic
0,163  0,090  Succinate dehydrogenase inhibitor
0,105  0,033  ATPase (Vacuolar H+) inhibitor
0,162  0,092  Antineoplastic (bone cancer)
0,147  0,078  GABA C receptor rho-2 antagonist
0,143  0,076  Hemostatic
0,076  0,009  Adenylate cyclase 1 inhibitor
0,193  0,127  Antiprotozoal (Trypanosoma)
0,106  0,042  Phosphodiesterase 6D inhibitor
0,071  0,009  Squalene synthetase inhibitor
0,140  0,078  Cyclooxygenase inhibitor
0,115  0,053  MAO B inhibitor
0,077  0,016  Leukotriene B4 antagonist
0,115  0,055  Multidrug resistance-associated protein 1 inhibitor
0,153  0,096  ATPase inhibitor
0,102  0,045  Alpha 2d adrenoreceptor antagonist
0,101  0,044  Phosphodiesterase IV inhibitor
0,091  0,035  Glutamate decarboxylase inhibitor
0,087  0,031  Phosphodiesterase VI inhibitor
0,061  0,009  Diamine oxidase inhibitor
0,186  0,134  Lipoprotein disorders treatment
0,138  0,086  NOS3 expression enhancer
0,157  0,107  Clk dual-specificity kinase inhibitor
0,079  0,029  Glutamate (mGluR7) antagonist
0,090  0,041  Phosphodiesterase 4D inhibitor
0,084  0,035  Alpha adrenoreceptor agonist
0,053  0,006  Leukotriene B4 receptor 1 antagonist
0,070  0,026  Postmenopausal disorders treatment
0,054  0,010  Vesicle monoamine transporter inhibitor
0,198  0,156  5 Hydroxytryptamine uptake stimulant
0,080  0,039  Calcium channel L-type blocker
0,085  0,045  Alpha 2a adrenoreceptor antagonist
0,116  0,077  Epidermal growth factor receptor kinase inhibitor
0,096  0,057  GST P1-1 substrate
0,126  0,086  Neurotrophic factor
0,042  0,004  Imidazoline I1 receptor antagonist
0,159  0,121  Insulin sensitizer
0,060  0,023  Anesthetic inhalation
0,132  0,097  Eye irritation, high
0,102  0,067  Expectorant
0,110  0,075  Sphingosine 1-phosphate receptor 2 agonist
0,157  0,123  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,072  0,039  Leukotriene antagonist
0,071  0,039  Dopamine D1 antagonist
0,116  0,084  Cyclooxygenase 2 inhibitor
0,049  0,020  Dihydrofolate reductase inhibitor
0,053  0,025  Carnitine palmitoyltransferase 1B inhibitor
0,129  0,102  UGT1A4 substrate
0,050  0,023  Phosphodiesterase 6C inhibitor
0,041  0,014  Melatonin agonist
0,173  0,147  RNA-directed DNA polymerase inhibitor
0,137  0,112  Interleukin 6 antagonist
0,121  0,099  Cytidine deaminase inhibitor
0,101  0,080  Electron transport complex I inhibitor
0,110  0,089  Contraceptive female
0,062  0,041  Neuraminidase inhibitor
0,037  0,018  Melatonin 1 agonist
0,082  0,065  Ornithine decarboxylase inhibitor
0,115  0,098  Protein kinase stimulant
0,061  0,045  5 Hydroxytryptamine 2A agonist
0,126  0,110  UGT2B9 substrate
0,108  0,093  Antiprotozoal (Amoeba)
0,028  0,014  Dopamine autoreceptor agonist
0,055  0,042  Postcoital contraceptive
0,110  0,098  Antibacterial (Helicobacter pylori)
0,082  0,070  Alpha adrenoreceptor antagonist
0,034  0,022  Melatonin 2 agonist
0,123  0,110  UGT2B7 substrate
0,127  0,115  Heat shock protein 90 alpha antagonist
0,119  0,109  Cholinergic
0,056  0,047  Heat shock protein 90 beta antagonist
0,091  0,082  Estrogen receptor beta antagonist
0,101  0,093  Antiviral (Hepatitis B)
0,134  0,127  Wound healing agent
0,012  0,006  Imidazoline I2 receptor antagonist
0,034  0,029  Inosine monophosphate dehydrogenase inhibitor
0,138  0,134  Non-steroidal antiinflammatory agent
0,138  0,134  Neurotensin receptor agonist
0,135  0,130  Antihelmintic
0,013  0,010  Melatonin receptor 1A antagonist
0,189  0,186  FMO3 substrate
0,031  0,029  Melatonin receptor 1A agonist
0,106  0,105  Antifungal (Pneumocystis)
0,049  0,049  Aromatase inhibitor
0,053  0,053  Dopamine D3 antagonist

